BDBM726103 [3a(4)Z,10R]-20-chloro-6,9,10,15- tetramethyl-10,11,13,15-tetrahydro-2H- 1,17-(ethanediylidene)imidazo[4,5- f]pyrazolo[4,3-m]pyrrolo[3,4- i][1,4]oxazacyclopentadecine- 3,8(5H,9H)-dione::US20250074920, Compound 8

SMILES Cc1nc2c([nH]1)/C=C1/C(=O)Nc3c(Cl)cc(cc31)-c1cn(C)nc1COC[C@@H](C)N(C)C2=O

InChI Key InChIKey=OSSPIWLXRHDVBI-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 726103   

TargetNon-receptor tyrosine-protein kinase TYK2 [888-1187](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 726103BDBM726103([3a(4)Z,10R]-20-chloro-6,9,10,15- tetramethyl-10,1...)
Affinity DataKd:  170nMAssay Description:Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17×PBS, 0.05...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/10/2025
Entry Details
US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [575-869](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 726103BDBM726103([3a(4)Z,10R]-20-chloro-6,9,10,15- tetramethyl-10,1...)
Affinity DataKd: >1.00E+4nMAssay Description:Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17×PBS, 0.05...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/10/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2 [536-812](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 726103BDBM726103([3a(4)Z,10R]-20-chloro-6,9,10,15- tetramethyl-10,1...)
Affinity DataKd: >1.00E+4nMAssay Description:Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17×PBS, 0.05...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/10/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3 [521-781](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 726103BDBM726103([3a(4)Z,10R]-20-chloro-6,9,10,15- tetramethyl-10,1...)
Affinity DataKd: >1.00E+4nMAssay Description:Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17×PBS, 0.05...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/10/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1 [583-855](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 726103BDBM726103([3a(4)Z,10R]-20-chloro-6,9,10,15- tetramethyl-10,1...)
Affinity DataKd: >1.00E+4nMAssay Description:Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17×PBS, 0.05...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/10/2025
Entry Details
US Patent